4basebio plc (4BB) ORD EUR1
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
785.00p
820.00p
1,380.00p
£121.56 million
785.00p
750.00p
715.00p
n/a
0.00p (0.00%) Previous:
0.00p
151
n/a
200
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | 0.93 | 0.51 |
| Profit before tax (£m) | (12.65) | (8.35) |
| Adjusted EPS (p): | (0.94) | (0.62) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
4basebio partner starts dosing patients in opDNA-based trial
27 October 2025 12:06
-
4basebio reports strong full-year progress
27 May 2025 10:09
-
4basebio's Cambridge facility gets GMP certification
2 April 2025 10:49
-
Synthetic opDNA® utilised in Phase I/II US clinical trials
27 October 2025 07:00
-
Result of Extraordinary General Meeting
10 October 2025 11:30
-
Director Dealing
30 September 2025 16:20
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.